Guido Wabnitz

7PUBLICATIONS
27CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 21, 2026
Reply to Letter: "Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring" by Saccà and Pelto Regarding "Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab".

|Nov 20, 2025
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab.

Lea Gerischer, Frauke Stascheit, Maximilian Mönch

|Dec 08, 2023
Human and mouse neutrophils share core transcriptional programs in both homeostatic and inflamed contexts.

Nicolaj S Hackert, Felix A Radtke, Tarik Exner

|Jun 02, 2021
Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.

Emre Balta, Guido H Wabnitz, Yvonne Samstag

|Jan 15, 2021
LFA-1 cluster formation in T-cells depends on L-plastin phosphorylation regulated by P90RSK and PP2A.

Guido H Wabnitz, Sibylle Honus, Jüri Habicht

|Sep 11, 2019
Spatial oxidation of L-plastin downmodulates actin-based functions of tumor cells.

Emre Balta, Robert Hardt, Jie Liang

Pageof 2

Frequent Collaborators

2 joint publications

Emre Balta

2 joint publications

Andreas Meisel

2 joint publications

Yvonne Samstag

2 joint publications

Jutta Schroeder-Braunstein